TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval by several foreign nations for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.
BRIUMVI® is a registered trademark of TG Therapeutics, Inc.
read more
HR or Marketing? Claim Your Free Employer Account
TG Therapeutics Leadership Employee Reviews
All
Positive
Constructive
What do you like best about the leadership team?
From the day I started, the Leadership Team has done everything possible to make TG a standout company. The work environment is excellent and they truly care about every employee!
You are not just an employee. You are seen everyday
What does the leadership team need to get better at?
Treat your staff how you would like to be treated.
Stop stealing people's ideas and claiming them as your own.
Leadership needs to understand that those who work under you are human too. They also need to understand that not all of them are going to be perfect and that being a manager is about helping your team succeed.
×